Insider buying
~$31K25K sh @ $1.25
Traded Aug 25, 2025 · filed the same day
A Cerus director paid $31K out of pocket for Cerus shares. It was the first purchase in 8 months. Shares held went up 41% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CERS · NASDAQ · Surgical & Medical Instruments & Apparatus
Cerus (CERS) · oqro.io/stocks/CERS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$1.90−0.04 (−2.06%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day
Insider buying
Traded Aug 25, 2025 · filed the same day
A Cerus director paid $31K out of pocket for Cerus shares. It was the first purchase in 8 months. Shares held went up 41% with this purchase.
William Mariner Greenman (President and CEO) sold ~$178K of Cerus
Planned saleWilliam Mariner Greenman (President and CEO) sold ~$103K of Cerus
Planned saleKevin Dennis Green (Chief Financial Officer) sold ~$53K of Cerus
Planned saleKevin Dennis Green (Chief Financial Officer) sold ~$34K of Cerus
Planned saleVivek K Jayaraman (Chief Operating Officer) sold ~$67K of Cerus
Planned saleChrystal Jensen (Chief Legal Officer) sold ~$44K of Cerus
Planned saleRichard J Benjamin (Chief Medical Officer) sold ~$44K of Cerus
Planned saleVivek K Jayaraman (Chief Operating Officer) sold ~$43K of Cerus
Planned saleChrystal Jensen (Chief Legal Officer) sold ~$27K of Cerus
Planned saleRichard J Benjamin (Chief Medical Officer) sold ~$27K of Cerus
Planned saleWilliam Mariner Greenman (President and CEO) sold ~$91K of Cerus
Planned saleKevin Dennis Green (Chief Financial Officer) sold ~$47K of Cerus
Planned saleVivek K Jayaraman (Chief Operating Officer) sold ~$51K of Cerus
Planned saleChrystal Jensen (Chief Legal Officer) sold ~$41K of Cerus
Planned saleRichard J Benjamin (Chief Medical Officer) sold ~$39K of Cerus
Planned saleKevin Dennis Green (Chief Financial Officer) sold ~$96K of Cerus
Planned saleWilliam Mariner Greenman (President and CEO) sold ~$36K of Cerus
Planned saleChrystal Jensen (Chief Legal Officer) sold ~$95K of Cerus
Planned saleRichard J Benjamin (Chief Medical Officer) sold ~$81K of Cerus
Planned saleKevin Dennis Green (Chief Financial Officer) sold ~$13K of Cerus
Planned saleVivek K Jayaraman (Chief Operating Officer) sold ~$17K of Cerus
Planned saleRichard J Benjamin (Chief Medical Officer) sold ~$9.7K of Cerus
Planned saleChrystal Jensen (Chief Legal Officer) sold ~$9.7K of Cerus
Planned saleInsider buying
Traded Dec 13, 2024 · filed 20 days later
A Cerus director paid $2.9K out of pocket for Cerus shares.
Insider selling
Traded Dec 12, 2024 · filed 5 days laterNot reported under a pre-arranged trading plan
A Cerus director sold $36K of Cerus shares. The filing does not indicate a pre-arranged trading plan.
Chrystal Jensen (Chief Legal Officer) sold ~$29K of Cerus
Planned sale0 open-market purchases and 0 open-market sales by insiders of CERS between Jan 31, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 2, 2026. The data provider lists the next release for Mar 1, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 2, 2026 | None | None | None |
| Jul 30, 2026 | None | None | None |
| Apr 30, 2026 | None | None | None |
| Mar 2, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies